RVPH:NASDAQReviva Pharmaceuticals Holdings, Inc. Analysis
Data as of 2026-08-31 - not real-time
$0.48
Latest Price
9/10Risk
Risk Level: High
Executive Summary
The moving-average structure behind Reviva Pharmaceuticals Holdings, Inc. is bearish at $0.4800, with short-term averages lagging the long-term ones. The last 30 days have lost 11.1%. Relative strength is 47.7 — neutral — and the MACD signal is bullish. Price has been bracketed by support at $0.4000 and resistance at $0.5492.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. The average analyst target implies 3545.8% above today's level.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 145.1%, a beta of 2.11 and a maximum drawdown of 98.0%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
The horizons line up on hold — conviction 1 out of 10.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. The average analyst target implies 3545.8% above today's level.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 145.1%, a beta of 2.11 and a maximum drawdown of 98.0%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
The horizons line up on hold — conviction 1 out of 10.
Top Market Events
By John Vandermosten, CFA OTCQB: RVPH READ THE FULL RVPH RESEARCH REPORT Reviva Pharmaceuticals Holdings, Inc.Nasdaq18dReviva Reports Second Quarter 2026 Financial Results and Recent Business Highlights- FDA feedback on use of...Track Reviva Pharmaceuticals Holdings Inc.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 2/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 3.51
- MACD momentum is positive
Medium Term
1–3 yearsNeutral
Model confidence: 1/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 3.51
- Analyst targets imply +3545.8% versus the current price
Long Term
> 3 yearsNeutral
Model confidence: 1/10
Key Factors
- Analyst targets imply +3545.8% versus the current price
- Negative return on equity of -176.6%
- Negative free cash flow
Key Metrics & Analysis
Financial Health
P/E Ratio-0.6
ROE-176.60%
ROA-51.40%
Debt/Equity0.95
P/B Ratio0.4
Op. Cash Flow$-17304396
Free Cash Flow$-13689651
Industry P/E30.4
Technical Analysis
TrendBearish
RSI47.7
Support$0.40
Resistance$0.55
MA 20$0.48
MA 50$0.53
MA 200$3.51
MACDBullish
VolumeDecreasing
Fear & Greed Index94.84
Valuation
Target Price$17.50
Upside/Downside3545.83%
GradeUndervalued
TypeBlend
Risk Assessment
Beta2.11
Volatility145.13%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.